Differences in glycemic control between the treatment arms in cardiovascular outcome trials of type 2 diabetes medications do not explain cardiovascular benefits

by George, J.T, Inzucchi, S.E, Johansen, O.E, Marx, N., McGuire, D.K, Rosenstock, J.
Published 2021

Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HF

by Bengtsson, O., DAPA-HF Investigators and Committees, Docherty, K.F, Inzucchi, S.E, Jhund, P.S, Køber, L., Kosiborod, M.N, Langkilde, A.M, Lindholm, D., Martinez, F.A, McMurray, J.J.V, Ponikowski, P., Sabatine, M.S, Simpson, J., Sjöstrand, M., Solomon, S.D
Published 2022

Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF

by Anand, I.S, Bengtsson, O., Chiang, C.-E, Chopra, V.K, Desai, A.S, Docherty, K.F, Inzucchi, S.E, Jhund, P.S, Kitakaze, M., Køber, L., Kosiborod, M.N, Langkilde, A.M, Martinez, F.A, McMurray, J.J.V, Ponikowski, P., Sabatine, M.S, Sjöstrand, M., Solomon, S.D, Verma, S., Vinh, P.N
Published 2022

Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction

by Anand, I.S, Bengtsson, O., Desai, A.S, Diez, M., Docherty, K.F, Howlett, J.G, Inzucchi, S.E, Jhund, P.S, Køber, L., Kosiborod, M.N, Langkilde, A.M, Lindholm, D., Martinez, F.A, McMurray, J.J.V, Nicolau, J.C, Ogunniyi, M.O, O'Meara, E., Ponikowski, P., Sabatine, M.S, Sjöstrand, M., Solomon, S.D, Verma, S.
Published 2022

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

by Anderson, J.E, Bakris, G.L, Ballantyne, C.M, Beckman, J.A, Bhatt, D.L, Bloomgarden, Z.T, Bozkurt, B., Budoff, M.J, Butler, J., Dagogo-Jack, S., de Boer, I.H, DeFronzo, R.A, Eckel, R.H, Einhorn, D., Fonseca, V.A, Green, J.B, Grunberger, G., Guerin, C., Handelsman, Y., Inzucchi, S.E, Jellinger, P.S, Kosiborod, M.N, Kushner, P., Lepor, N., Mende, C.W, Michos, E.D, Plutzky, J., Taub, P.R, Umpierrez, G.E, Vaduganathan, M., Weir, M.R
Published 2022

Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial

by Al Habeeb, W., Alcocer Gamba, M.A, Belohlavek, J., Cabrera Honorio, J.W, Chiang, C.-E, Claggett, B.L, Comin-Colet, J., de Boer, R.A, DeMets, D., Dobreanu, D., Drozdz, J., Fang, J.C, Han, Y., Hernandez, A.F, Inzucchi, S.E, Janssens, S.P, Katova, T., Kerr Saraiva, J.F, Kitakaze, M., Kosiborod, M.N, Lam, C.S.P, Lindholm, D., Martinez, F., McMurray, J.J.V, Merkely, B., O'Meara, E., Petersson, M., Shah, S.J, Solomon, S.D, Tereschenko, S.N, Thierer, J., Vaduganathan, M., Vardeny, O., Verma, S., Vinh, P.N, Wilderäng, U., Willem Borleffs, C.J, Zaozerska, N.
Published 2022